The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
23-Nov-12
$NA
Target:
SAS Group
Acquiror:
Norwegian Government
Advised the Norwegian Government in relation to some specific issues in connection with the restructuring of SAS, the leading airline group in Northern Europe
05-Feb-14
$NA
Target:
Unfors Raysafe AB
Acquiror:
Fluke Biomedical Corporation
Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products
09-Sep-14
$NA
Target:
Atwood Mobile Products, LLC
Acquiror:
Dometic Group AB
Advised Dometic Group AB, a portfolio company of EQT, on its acquisition of Atwood Mobile Products, a global manufacturer of appliances and hardware for the RV, On-/Off-Highway and Marine industries
14-Dec-17
$NA
Target:
36.5% stake in DNV GL Group AS
Acquiror:
Det Norske Veritas Holding AS
Advised Det Norske Veritas Holding AS (“DNV”) on its acquisition of the 36.5% stake in DNV GL Group AS it did not already own from Mayfair Vermögensverwaltungs SE, whereby DNV is becoming the sole shareholder and regaining full control of DNV GL
21-Aug-07
$NA
Target:
Schenck Process Holding GmbH
Acquiror:
Industri Kapital Limited
Advised HgCapital on the sale of Schenck Process, one of the global market leading providers of industrial weighing, feeding, screening and automation equipment and solutions
07-Aug-08
$NA
Target:
Scholastic Corporation’s U.S. direct-to-home continuities business
Acquiror:
Sandvik AS
Advised Scholastic, the global children’s publishing, education and media company, on the sale of its U.S. direct-to-home continuities business to Sandvik AS
02-Mar-20
$NA
Target:
Global rights (excluding North America) to ThermaCare (United Kingdom)
Acquiror:
Angelini Pharma
Advised GlaxoSmithKline plc (“GSK”), the UK listed international pharmaceutical and consumer healthcare company, on the divestiture of the global rights (excluding North America) for ThermaCare, including a dedicated manufacturing facility based in Albany, Georgia, USA, to Angelini Pharma
22-Sep-20
$NA
Target:
VX Fiber
Acquiror:
AMP Capital
Advised VX Fiber, an international infrastructure and technology business focused on Fibre-to-the-Home networks, on its sale to the infrastructure fund AMP Capital
06-May-11
$NA
Target:
Aker Solutions (Aker Holding)
Acquiror:
Norwegian Government
Advised the Norwegian Government on strategic and financial matters in relation to its investment in Aker Holding, the largest shareholder of Aker Solutions during the demerger of the company’s EPC activities
22-Jun-11
$NA
Target:
KemFine Group Oy
Acquiror:
CABB AG
Advised 3i on the disposal of KemFine Group Oy, a leading custom manufacturer of fine chemicals, to CABB AG
22-Dec-11
$NA
Target:
KEMA
Acquiror:
Det Norske Veritas AS
Advised Det Norske Veritas, a global provider of services for managing risk, on its acquisition of a 74.3% stake in KEMA, a leading provider of energy consulting and testing & certification services
20-Dec-12
$NA
Target:
Germanischer Lloyd
Acquiror:
Det Norske Veritas
Advised Det Norske Veritas on its merger with Germanischer Lloyd to create the third largest player in the Testing, Inspection and Certification industry, focused on ship classification, oil & gas and energy
17-Dec-19
~$35 million
Target:
Sye business area of Net Insight AB
Acquiror:
Amazon.com, Inc.
Advised Net Insight AB, a global leader in media networks, on the sale of Sye, a market-leading true live “over-the-top” (OTT) technology for low-latency live streaming, to Amazon.com, Inc.
01-Oct-08
$53 million
Target:
Biotage (Biosystems division)
Acquiror:
Qiagen NV
Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research
21-Jan-19
$100 million
Target:
UQM Technologies, Inc.
Acquiror:
Danfoss A/S
Advised Danfoss, a global leader in power solutions, heating, cooling and drives, on its acquisition of UQM Technologies
13-Jan-05
$153 million
Target:
Deutz AG
Acquiror:
Wärtsilä Oyj
Advised Marine Service business Deutz on the sale of its marine service business for medium and large size engines to Wärtsilä
26-Feb-18
$224 million
Target:
Crem International
Acquiror:
Welbilt
Advised Welbilt, a leading global provider of commercial foodservice equipment on its acquisition of Crem International, a leading manufacturer of professional coffee machines
16-Jul-04
$275 million
Target:
Malmberg Investments
Acquiror:
SanomaWSOY
(majority owned by 3i Group plc)
Advised 3i and Malmberg's management on the sale of educational publisher Malmberg Investments to SanomaWSOY. The transaction represents 3i's largest exit in Continental Europe.
03-Oct-06
$445 million
Target:
Tele2 AB’s fixed telephony and broadband business in France
Acquiror:
SFR S.A.
Advised SFR S.A., the second largest mobile telecoms operator in France on the acquisition of the French fixed telephony and broadband business of Tele2 AB
09-Feb-10
$672 million
Target:
SAS Group
Acquiror:
Norwegian Government
Advised the Norwegian Government on strategic and financial matters in relation to a refinancing including a conditional capital injection in SAS, the leading airline group in Northern Europe
03-Feb-09
$717 million
Target:
SAS Group
Acquiror:
Norwegian Government
Advised the Norwegian Government in relation to a capital injection in SAS, the leading airline group in Northern Europe
11-Nov-99
$732 million
Target:
Indigo Aviation AB
Acquiror:
AerFi Group plc
Advised AerFi Group on its acquisition of Indigo Aviation. The transaction involved a negotiated purchase of 72% of Indigo for shares of AerFi followed by a cash tender offer for the remaining 28% of the outstanding Indigo shares.
21-Dec-12
$3.7 billion
Target:
NewPage Corp.
Advised Stora Enso Oyj, a global paper, packaging and wood products producer headquartered in Helsinki, Finland, in connection with the Chapter 11 proceeding of NewPage, the largest North American coated-paper manufacturer
10-Jun-20
$3.9 billion
Target:
Global collaboration agreement with Genmab A/S
Acquiror:
AbbVie, Inc
Advised AbbVie, Inc, an NYSE-listed global biopharmaceutical company, on a broad collaboration with Genmab A/S, a leading Danish-listed biotechnology company, to jointly develop and commercialise three next-generation bispecific antibody programs
03-May-07
$8.5 billion
Target:
IPSCO Inc.
Acquiror:
SSAB Svenskt Stål AB
Acted as lead financial advisor to SSAB Svenskt Stål AB on its acquisition of IPSCO Inc., a leading Canadian producer of energy tubulars and steel plate in North America with an annual steel making capacity of 4.3 million tons